140 related articles for article (PubMed ID: 555224)
1. [New aspects in the clinical course determination and therapy in multiple myeloma].
Ludwig H; Pietschmann H
Acta Med Austriaca; 1979; 6(5):255-60. PubMed ID: 555224
[TBL] [Abstract][Full Text] [Related]
2. Multiple myeloma: a therapeutic enigma.
Hoogstraten B
Am J Clin Oncol; 1982 Feb; 5(1):13-9. PubMed ID: 7081135
[TBL] [Abstract][Full Text] [Related]
3. [Determination of the tumor cell mass and its significance as a parameter for prognosis and therapy in patients with multiple myeloma].
Ludwig H; Schneider K; Pietschmann H
Acta Med Austriaca; 1978; 5(4-5):164-6. PubMed ID: 756132
[TBL] [Abstract][Full Text] [Related]
4. A new basis for treatment of multiple myeloma.
Salmon SE; Durie BG; Hamburger AW
Schweiz Med Wochenschr; 1978 Oct; 108(41):1568-72. PubMed ID: 694483
[TBL] [Abstract][Full Text] [Related]
5. [Results of treatment of patients with advanced multiple myeloma with the vincristine-adriamycin-dexamethasone protocol].
Marisavljević D; Bosković D; Radosević N; Elezović I; Tomin D; Gotić M; Antunović P
Srp Arh Celok Lek; 1996; 124(11-12):292-6. PubMed ID: 9132962
[TBL] [Abstract][Full Text] [Related]
6. [Current status of treatment for multiple myeloma].
Tsuchiya J
Gan To Kagaku Ryoho; 1982 Nov; 9(11):1911-20. PubMed ID: 7184381
[TBL] [Abstract][Full Text] [Related]
7. [The treatment of multiple myeloma].
Ludwig H; Kührer I
Wien Klin Wochenschr; 1994; 106(14):448-54. PubMed ID: 7941591
[TBL] [Abstract][Full Text] [Related]
8. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
9. [Interferon therapy in multiple myeloma].
Micksche M
Wien Med Wochenschr; 1993; 143(16-17):425-8. PubMed ID: 8273366
[TBL] [Abstract][Full Text] [Related]
10. Individualized chemotherapy in multiple myeloma by cytostatic drug sensitivity testing of colony-forming stem cells.
Ludwig H; Fritz E
Anticancer Res; 1981; 1(6):329-34. PubMed ID: 7344610
[TBL] [Abstract][Full Text] [Related]
11. Evolution of multiple myeloma treatment from melphalan monotherapy to bone marrow transplantation.
Hájek R; Adam Z; Vásová I; Král Z
Acta Med Austriaca; 1996; 23(3):85-91. PubMed ID: 8798281
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy with interleukin-6 receptor superantagonist Sant7 and dexamethasone induces antitumor effects in a novel SCID-hu In vivo model of human multiple myeloma.
Tassone P; Neri P; Burger R; Savino R; Shammas M; Catley L; Podar K; Chauhan D; Masciari S; Gozzini A; Tagliaferri P; Venuta S; Munshi NC; Anderson KC
Clin Cancer Res; 2005 Jun; 11(11):4251-8. PubMed ID: 15930364
[TBL] [Abstract][Full Text] [Related]
13. Comparison of high-dose melphalan with a more intensive regimen of thiotepa, busulfan, and cyclophosphamide for patients with multiple myeloma.
Anagnostopoulos A; Aleman A; Ayers G; Donato M; Champlin R; Weber D; Alexanian R; Giralt S
Cancer; 2004 Jun; 100(12):2607-12. PubMed ID: 15197803
[TBL] [Abstract][Full Text] [Related]
14. [Progress in the treatment of multiple myeloma].
Wada M; Mizoguchi H
Gan To Kagaku Ryoho; 1997 Jul; 24(9):1079-88. PubMed ID: 9239160
[TBL] [Abstract][Full Text] [Related]
15. Comparison of two combination chemotherapy regimens for multiple myeloma: methyl-CCNU, cyclophosphamide, and prednisone versus melphalan and prednisone.
Cavagnaro F; Lein JM; Pavlovsky S; Becherini JO; Pileggi JE; Micheo EQ; Jait C; Musso A; Suárez A; Pizzolato M
Cancer Treat Rep; 1980 Jan; 64(1):73-9. PubMed ID: 6991106
[TBL] [Abstract][Full Text] [Related]
16. [Therapy of multiple myeloma].
La Verde G; Pulsoni A; Petrucci MT; Mandelli F
Recenti Prog Med; 1997 Apr; 88(4):186-93. PubMed ID: 9206817
[TBL] [Abstract][Full Text] [Related]
17. Severe combined immunodeficiency (SCID) mouse modeling of P-glycoprotein chemosensitization in multidrug-resistant human myeloma xenografts.
Bellamy WT; Odeleye A; Huizenga E; Dalton WS; Weinstein RS; Grogan TM
Clin Cancer Res; 1995 Dec; 1(12):1563-70. PubMed ID: 9815957
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of multiple myeloma--melphalan monotherapy after bone marrow transplantation].
Hájek R; Adam Z; Krejcí M; Vásová I; Král Z; Vorlícek J
Vnitr Lek; 1996 Apr; 42(4):278-84. PubMed ID: 8693716
[TBL] [Abstract][Full Text] [Related]
19. [Current and future approaches to therapy for multiple myeloma].
Nara N
Gan To Kagaku Ryoho; 1995 Jan; 22(1):9-15. PubMed ID: 7826084
[TBL] [Abstract][Full Text] [Related]
20. [Proteasome inhibition: a new therapeutic approach for the treatment of multiple myeloma].
Mikala G; Jákó J; Vályi-Nagy I
Orv Hetil; 2004 Jan; 145(2):67-74. PubMed ID: 14978877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
